ArticleLeukemia2020

Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols.

Alexander Popov et al.PubMed ↗Publisher ↗

No numbers read from the abstract.